Divi's Laboratories Posts Stellar Q1 Earnings on Surging Profitability
The API maker's net profit jumped 65.5% year-on-year, significantly outpacing revenue growth and driving its net profit margin to a multi-quarter high.
Divi's Laboratories reported robust Q1 FY27 results, with profit surging 65.5% on a 27.8% rise in revenue. The company's net profit margin expanded sharply to 29.3%.
Divi's Laboratories delivered a powerful start to fiscal 2027, with both revenue and profit showing strong sequential and annual growth. The standout feature was a dramatic expansion in profitability, as net profit grew more than twice as fast as sales.
Revenue for the quarter ended June 2026 rose to ₹3,080 crore, marking a healthy 27.8% increase from the same period last year and an 8.8% gain over the previous quarter. Profit after tax surged to ₹902 crore, climbing an impressive 65.5% year-on-year and 20.1% sequentially. This profit surge was fueled by significant operating leverage, lifting the net profit margin to 29.3%—a substantial 670 basis point improvement from Q1 FY26 and the highest level in at least the last five quarters.
The company's earnings momentum has been building. The table below shows a clear upward trajectory in both top-line and bottom-line performance over the recent quarters.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period Ended | June 2026 | March 2026 | June 2025 |
| Revenue (₹ Cr) | 3,080YoY +28% | 2,831 | 2,410 |
| Profit (₹ Cr) | 902YoY +66% | 751 | 545 |
| Net Profit Margin (%) | 29.3YoY +30% | 26.5 | 22.6 |
This operational strength is underpinned by a pristine balance sheet, with zero debt and a robust interest coverage ratio. The stock's strong one-year return of 38.2% reflects market anticipation of this performance, though it now trades at a significant premium to the industry. The key question is whether Divi's can sustain this elevated level of profitability in the quarters ahead.
Live Chart
· DIVISLAB
(BSE)
ISIN: INE361B01024
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.